Invention Grant
- Patent Title: Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
-
Application No.: US13480526Application Date: 2012-05-25
-
Publication No.: US08541564B2Publication Date: 2013-09-24
- Inventor: James W. Lillard, Jr.
- Applicant: James W. Lillard, Jr.
- Applicant Address: US GA Atlanta
- Assignee: Morehouse School of Medicine
- Current Assignee: Morehouse School of Medicine
- Current Assignee Address: US GA Atlanta
- Agency: Andrews Kurth LLP
- Agent Ping Wang
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12P21/04 ; C12P21/06 ; C12P21/08 ; C07K1/00
Abstract:
This application is directed to chemokine-immunoglobulin fusion polypeptides and chemokine-polymer conjugates. The fusion polypeptides and conjugates can be used for treating chemokine receptor-mediated disorders and modulating inflammation, inflammatory cell motility, cancer cell motility, or cancer cell survival.
Public/Granted literature
- US20120308565A1 CHEMOKINE-IMMUNOGLOBULIN FUSION POLYPEPTIDES, COMPOSITIONS, METHOD OF MAKING AND USE THEREOF Public/Granted day:2012-12-06
Information query
